secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2023-06-30T23:59:59+00:00
Accession:  0001437749-23-018959
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia terminates Lincoln Park equity line, lifts Cantor ATM suspension
--------------------------------------------------------------------------

- Terminated Purchase Agreement with Lincoln Park Capital effective July 3, 2023; no further share sales allowed.
- Resumes sales under Cantor Fitzgerald Controlled Equity Offering Sales Agreement dated April 12, 2022.
- Financing shift: replaces existing equity line with ATM facility for future capital raises.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774923018959/0001437749-23-018959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774923018959/bcda20230629_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-018959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer